Table 2.
US findings | GI‐GVHD (n = 32) | Non GI‐GVHD | |
---|---|---|---|
Non‐GVHD enteritis (n = 26) | No gastrointestinal symptoms (n = 23) | ||
Wall thickening (%) | |||
Stomach | 18 (56) | 6 (23)a | 4 (17)a |
Duodenum | 8 (29) | 2 (8) | 1 (4) |
Jejunum | 12 (40) | 4 (15) | 2 (9)a |
Ileum | 23 (74) | 7 (27)a | 5 (22)a |
Right‐sided colon | 17 (57) | 8 (31) | 3 (13)a |
Left‐sided colon | 17 (57) | 3 (12)a | 1 (4)a |
Rectum | 12 (40) | 2 (8)a | 2 (9)a |
Internal low echoic layer (mm) | 2.0 ± 0.7 | 0.9 ± 0.5a | 0.8 ± 0.4a |
No. of affected segments | 3.3 ± 1.9 | 1.2 ± 1.2a | 0.8 ± 0.7a |
Dilatation (%) | |||
Jejunum | 6 (18) | 5 (19) | 1 (4) |
Ileum | 5 (16) | 2 (8) | 1 (4) |
Right‐sided colon | 11 (36) | 3 (12)a | 2 (9)a |
Left‐sided colon | 9 (29) | 3 (12) | 1 (4) |
Hyperechoic meseteric fat (%) | 17 (61) | 1 (4)a | 1 (4)a |
Increased Doppler signal (%) | 14 (56) | 1 (4)a | 1 (4)a |
Ascites (%) | 23 (72) | 17 (65) | 18 (78) |
p < 0.05, GI‐GVHD patients were compared to non‐GVHD enteritis and no GI‐GVHD symptoms (Tukey's honestly significant difference test).